Taro-Deferasirox (Type J) 360 mg

TARO-DEFERASIROX (TYPE J) 360 MG tablets are an oral medication used for managing iron overload. This pharmaceutical product, manufactured by TARO Pharmaceuticals Inc., helps in reducing excess iron in the body.

TARO-DEFERASIROX (TYPE J) 360 MG tablets are primarily used for the treatment of chronic iron overload due to blood transfusions. This medication is designed to help manage conditions where the body has too much iron, which can occur in certain medical treatments or disorders. Deferasirox is often prescribed to patients who require regular blood transfusions, as these can lead to iron accumulation over time.

Common effects of TARO-DEFERASIROX (TYPE J) 360 MG tablets may include gastrointestinal issues such as nausea, vomiting, or diarrhea. Some users might experience skin rash or changes in kidney function. It is important to monitor for any adverse reactions and consult a healthcare provider if significant side effects occur.

TARO-DEFERASIROX (TYPE J) 360 MG tablets should be handled with care, following the prescribed dosage and administration guidelines. Patients with pre-existing kidney or liver conditions should use this medication under close medical supervision. Regular monitoring of iron levels and kidney function is recommended during treatment.

TARO-DEFERASIROX (TYPE J) 360 MG tablets may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. Alcohol consumption should be avoided as it can exacerbate potential side effects. Always inform your healthcare provider about all medications and supplements you are taking to avoid adverse interactions.